Global Microbial Gene Editing Market Opportunities, Analysis, Demand and Trends 2022-2032
Microbial Gene
Editing Services: Market Dynamics
Recent research and development in genome editing technologies hold
promise in the forecast period for the development of innovative therapies. Use
of genome tools has the potential to affect various therapeutic areas and
hundreds of disease, common and rare disease which will significantly boost the
market of microbial gene editing services in the forecast period. Increased
attention given for the development of new antimicrobials which fight against
antibiotic-resistant bacteria will drive the market for microbial gene editing
services in near future. For instance, Companies such as Nemesis Bioscience and
Eligo Bioscience are developing antimicrobial technology and treatments with
the help of CRISPR technology. Increasing government funding and development of
fast and east methods with high efficiency spur the microbial gene editing
services market in forecast period. However, certain limitations to the
available tool and high cost associated with the editing systems might
restraint the growth of microbial gene editing services market.
Microbial Gene
Editing Services: Overview
Rising acceptance and increasing medical research and development for
gene editing will rise the growth of market in the near future. Growth of
established and new gene editing tools is expected to spur the overall market
of microbial gene editing services market. Rising clinical trial for diseases
as diverse as muscular dystrophy, cancer, and sickle cell anaemia will further
drive the microbial gene editing services market. There are approximately 2,700
clinical trials using gene therapies under way or approved around the world.
Furthermore increasing number of skilled labors will create opportunity for
development of new tools in future which will bring significant growth in the
revenue of microbial gene editing services market in the forecast period.
Microbial Gene
Editing Services: Region-wise Outlook
The North America market for Microbial Gene Editing Services holds the
largest revenue share, due to increasing research and development and rising
government funding towards the microbial gene editing research. For instance,
in 2018, The US National Institutes of Health (NIH) has announced to grant
US$190 million for genome editing research. Launch of genome editing program by
NIH such as Somatic Cell Genome Editing programs which aims to develop tools
for safe and effective genome editing in humans spur the market of North
America in the forecast period. Europe accounts for the second large revenue
share in the global microbial gene editing services market, owing to increasing
prevalence of disease such as HIV and Cancer and development of new innovative
technology and new drug along with the increasing number skilled labors. Asia
Pacific is expected to witness rapid growth in the microbial gene editing
services market, due to increasing awareness in the gene editing services in
developing countries such as India and improving healthcare infrastructure.
China is expected to register significant growth in the microbial gene editing
services market, due to favorable regulations and advancement in the
biotechnology. For instance, the world’s first genetically edited babies was
created in China in 2018. Latin America and Middle East & Africa are
projected to exhibit slow growth in microbial gene editing services market,
owing to lack of R&D labs, awareness and high cost of gene editing tools
and systems
Microbial Gene
Editing Services: Key Players
Examples of some of the key service provider present in the global
microbial gene editing services market are Creative Biogene, GeneCopoeia, Inc.,
ProteoGenix, Thermo Fisher Scientific Inc., Vigene Biosciences Inc., Biotools
Co., Ltd, Cellecta, In, NemaMetrix Inc., GenScript Biotech Corp, OriGene
Technologies, Inc, Synbio Technologies LLC, abm Inc, Rockland Immunochemicals
Inc.among others.
Microbial Gene Editing Services:
Segmentation
The global Microbial Gene Editing Services Market is segmented on basis
of tools, application and geography.
Segmentation by
Tools
- Meganucleases
(MNs),
- Zinc
Finger Nucleases (ZFNs)
- Transcription
Activator-Like Effector Nucleases (TALENs)
- CRISPR/Cas9
- Targetrons
- Peptide
Nucleic Acids (PNAs)
- Triplex-Forming
Oligonucleotides (TFOs)
- Structure-Guided Endonucleases(SGNs)
Segmentation by
Application
- Industrial
Applications
- Pharmaceutical
applications
- Environmental
applications
- Agricultural
applications
Segmentation by End
User
- Biotechnological
Companies
- Pharmaceutical
Companies
- Contract
Research Organizations
- Academic
Research Institutes
Report Highlights:
- Shifting
Industry dynamics
- In-depth
market segmentation
- Historical,
current and projected industry size Recent industry trends
- Key
Competition landscape
- Strategies
of key players and product offerings
- Potential
and niche segments/regions exhibiting promising growth
- A neutral
perspective towards market performance
Read More @ https://www.futuremarketinsights.com/reports/microbial-gene-editing-services-market
Comments
Post a Comment